Last reviewed · How we verify
saline eye drops.
Saline eye drops work by lubricating the eyes to help relieve dryness and irritation.
Saline eye drops work by lubricating the eyes to help relieve dryness and irritation. Used for Dry eye syndrome, Eye irritation.
At a glance
| Generic name | saline eye drops. |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
They do this by creating a protective film on the surface of the eye, which helps to reduce friction and discomfort. This can be especially helpful for people who experience dry eye syndrome or have undergone eye surgery.
Approved indications
- Dry eye syndrome
- Eye irritation
Common side effects
- Eye irritation
Key clinical trials
- The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia (PHASE4)
- Losartan for Corneal Fibrosis (NA)
- Sublingual Atropine Bioequivalence by Route of Administration (SABER) (PHASE1)
- Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)
- Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II (PHASE3)
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients (PHASE4)
- Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests (PHASE4)
- Oral vs IV Sedation for Cataract Surgery in Older Adults (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- saline eye drops. CI brief — competitive landscape report
- saline eye drops. updates RSS · CI watch RSS
- Jiangsu HengRui Medicine Co., Ltd. portfolio CI